Cell And Gene Articles, App Notes, Case Studies, & White Papers

31. Automating High-Throughput Screens Using Patient-Derived Organoids 3/17/2025

    Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.

32. Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024) 8/19/2024

    CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.

33. Safer And Faster Conjugation And Purification Of ADCs At 1-20 L Scale 12/5/2023

    Explore data demonstrating the successful engineering of a single-use tangential flow filtration system designed to meet the specific requirements of ADC processes.

34. Production And Clarification Of Lentiviral Vectors 10/30/2024

    Explore scalable processes for lentiviral vector production and clarification at the 50 L scale, utilizing the CTS LV-MAX system and single-use bioreactors for robust gene therapy manufacturing.

35. Cleanroom Recovery. Proven Results. Contamination Control Case Studies 9/11/2025

    Through this collection, review how a proven, automated solution can help facilities stay compliant, operational, and protected — whether in a crisis or during planned maintenance.

36. Stability Of Supplemented PRIME-XV T Cell CDM At Room Temperature 10/17/2025

    Gain insight into how a supplemented medium stored at room temperature for up to 72 hours maintained T cell expansion performance, showing consistent viability and marker expression.

37. Development To Large-Scale cGMP Production 7/25/2024

    For manufacturers working with a dry powder medium (DPM), early consultation with a supplier can increase the likelihood of success. Uncover a two-phase scale-up strategy for the production of DPM.

38. Prefabricated Viral Vector Modular BSL-2LS cGMP Facility In 13 Months 6/26/2024

    Learn about the modular BSL-2LS cGMP facility that was constructed to support 3 processing lines for German-based CDMO Vibalogics as the company sought to expand in the U.S. market for viral vectors.

39. AAV-Based Gene Editing For Huntington's Disease 10/28/2025

    LETI-101 uses AAV5 to deliver a compact CRISPR system for allele-selective editing of mutant HTT, showing promise as a one-time treatment for Huntington’s disease with strong preclinical safety and efficacy.

40. Lentiviral Vector Production Using Single-Use Bioreactors 5/6/2024

    Here, we outline a scalable and robust upstream process developed for LVV production of HEK293T cells and demonstrate how to expand HEK293T suspension cells.